181 related articles for article (PubMed ID: 34986297)
1. Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats.
Yoon KT; Liu H; Zhang J; Han S; Lee SS
Clin Mol Hepatol; 2022 Apr; 28(2):232-241. PubMed ID: 34986297
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy.
Liu H; Lee SS
Liver Int; 2008 May; 28(5):640-8. PubMed ID: 18346133
[TBL] [Abstract][Full Text] [Related]
3. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Liu H; Ma Z; Lee SS
Gastroenterology; 2000 May; 118(5):937-44. PubMed ID: 10784593
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of erythropoietin on cirrhotic cardiomyopathy in rats.
Liu L; Liu H; Nam SW; Lee SS
Dig Liver Dis; 2012 Dec; 44(12):1012-7. PubMed ID: 22835858
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice.
Nam SW; Liu H; Wong JZ; Feng AY; Chu G; Merchant N; Lee SS
Clin Sci (Lond); 2014 Oct; 127(8):519-26. PubMed ID: 24712830
[TBL] [Abstract][Full Text] [Related]
6. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy.
Jaue DN; Ma Z; Lee SS
Hepatology; 1997 Jun; 25(6):1361-5. PubMed ID: 9185753
[TBL] [Abstract][Full Text] [Related]
7. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat.
Liu H; Song D; Lee SS
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G68-74. PubMed ID: 11123199
[TBL] [Abstract][Full Text] [Related]
8. Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids.
Gaskari SA; Liu H; D'Mello C; Kunos G; Lee SS
J Hepatol; 2015 Jun; 62(6):1272-7. PubMed ID: 25640062
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats.
Niaz Q; Tavangar SM; Mehreen S; Ghazi-Khansari M; Jazaeri F
Life Sci; 2022 Nov; 308():120966. PubMed ID: 36150464
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of Spermidine Against Cirrhotic Cardiomyopathy in Bile Duct-Ligated Rats.
Sheibani M; Nezamoleslami S; Mousavi SE; Faghir-Ghanesefat H; Yousefi-Manesh H; Rezayat SM; Dehpour A
J Cardiovasc Pharmacol; 2020 Sep; 76(3):286-295. PubMed ID: 32902943
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats.
Esmaeili Z; Niaz Q; Saffari PM; Dehpour AR; Rezayat SM; Jazaeri F
Life Sci; 2021 May; 273():119261. PubMed ID: 33652036
[TBL] [Abstract][Full Text] [Related]
12. Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy.
Abbas WA; Kasem Ahmed SM; Abdel Aal AM; Mahmoud AA; Abdelmalek MO; Mekky MA; Abozaid MA; Ibrahim AK
Turk J Gastroenterol; 2016 Jul; 27(4):367-74. PubMed ID: 27458853
[TBL] [Abstract][Full Text] [Related]
13. Silymarin Administration Attenuates Cirrhotic-induced Cardiac Abnormality in the Rats: A Possible Role of β
Bayat G; Mazloom R; Hashemi SA; Pourkhalili K; Fallah P; Shams A; Esmaeili P; Khalili A
Iran J Med Sci; 2022 Jul; 47(4):367-378. PubMed ID: 35919076
[TBL] [Abstract][Full Text] [Related]
14. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids.
Yang YY; Liu H; Nam SW; Kunos G; Lee SS
J Hepatol; 2010 Aug; 53(2):298-306. PubMed ID: 20626112
[TBL] [Abstract][Full Text] [Related]
16. Cirrhotic Cardiomyopathy Following Bile Duct Ligation in Rats-A Matter of Time?
Uhlig M; Hein M; Habigt MA; Tolba RH; Braunschweig T; Helmedag MJ; Arici M; Theißen A; Klinkenberg A; Klinge U; Mechelinck M
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175858
[TBL] [Abstract][Full Text] [Related]
17. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy.
Ma Z; Lee SS; Meddings JB
J Hepatol; 1997 Apr; 26(4):904-12. PubMed ID: 9126806
[TBL] [Abstract][Full Text] [Related]
18. Myocardial Dysfunction in Cirrhotic Cardiomyopathy is Associated with Alterations of Phospholamban Phosphorylation and IL-6 Levels.
Gregolin CS; do Nascimento M; Borges de Souza SL; Ferreira Mota GA; Bomfim GF; de Azevedo Melo Luvizotto R; Sugizaki MM; Zanati Bazan SG; Salomé de Campos DH; Dias MC; Correa CR; Cicogna AC; Ferreira do Nascimento A
Arch Med Res; 2021 Apr; 52(3):284-293. PubMed ID: 33220932
[TBL] [Abstract][Full Text] [Related]
19. Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy.
Matyas C; Erdelyi K; Trojnar E; Zhao S; Varga ZV; Paloczi J; Mukhopadhyay P; Nemeth BT; Haskó G; Cinar R; Rodrigues RM; Ait Ahmed Y; Gao B; Pacher P
Hepatology; 2020 Apr; 71(4):1391-1407. PubMed ID: 31469200
[TBL] [Abstract][Full Text] [Related]
20. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats.
Glenn TK; Honar H; Liu H; ter Keurs HE; Lee SS
J Hepatol; 2011 Dec; 55(6):1249-55. PubMed ID: 21703204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
